CASSAVA SCIENCES INC. - COMMON STOCK
2.5500
21-2月-25 15:45:00
15 分の遅延
株式
-0.1500
-5.56%
本日の幅
2.5500 - 2.8000
ISIN
N/A
ソース
NASDAQ
-
25 3 2024 08:13:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Announces Virtual Presentation at the AD/PD™ 2024 International Conference
04 3 2024 08:15:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
28 2 2024 08:14:00 提供 Nasdaq GlobeNewswire
-
07 2 2024 08:08:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Completes Dividend Distribution of Warrants to Shareholders
05 1 2024 08:12:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders
12 12 2023 08:13:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Appoints Three New Members to its Board of Directors
07 12 2023 15:01:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Reports Third Quarter 2023 Financial and Operating Results
07 11 2023 08:01:00 提供 Nasdaq GlobeNewswire
-
06 11 2023 08:15:00 提供 Nasdaq GlobeNewswire
-
MRI Data Suggest Simufilam is Not Associated with Amyloid-related Imaging Abnormalities (ARIA)
25 10 2023 08:15:00 提供 Nasdaq GlobeNewswire
-
Statement by Cassava Sciences Regarding an Internal CUNY Report Leaked to the Press
12 10 2023 22:43:21 提供 Nasdaq GlobeNewswire
-
Cassava Sciences to Present at the Jefferies Biotech CNS/Neuro Summit in NY
05 10 2023 08:15:00 提供 Nasdaq GlobeNewswire
-
02 10 2023 08:00:44 提供 Nasdaq GlobeNewswire
-
18 9 2023 08:15:00 提供 Nasdaq GlobeNewswire
-
11 9 2023 08:10:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Invited to Present in Four Upcoming Investor Conferences
06 9 2023 08:15:00 提供 Nasdaq GlobeNewswire
-
Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates
03 8 2023 08:07:00 提供 Nasdaq GlobeNewswire
-
05 7 2023 08:15:00 提供 Nasdaq GlobeNewswire
-
New Research Shows Simufilam Suppresses Overactive mTOR
27 6 2023 08:15:00 提供 Nasdaq GlobeNewswire
-
New Publication Highlights Basic Science Supporting Simufilam
12 6 2023 08:15:00 提供 Nasdaq GlobeNewswire